Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Herman

Showing results (651-660 of 892) with videos related to

Pageof 90
Sort By:
Transfusion|October 11, 2011
RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME)Jenny M Despotovic, Michele P Lambert, Jay H Herman, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 16, 2012
Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and ComplicationsW H Herman, R Pop-Busui, B H Braffett, et al.
Calcified Tissue International|January 1, 1980
Effects of 1 alpha-hydroxy vitamin D3 on the rachitic chick intestine: a comparison to the effects of 1,25-dihydroxyvitamin D3D D Bikle, R N Empson, R L Morrissey, et al.
Diabetes Care|September 30, 2003
Improving diabetes processes of care in managed careLiza L Ilag, Catherine L Martin, Bahman P Tabaei, et al.
Toxicology and Applied Pharmacology|December 6, 2018
Candidate early predictive plasma protein markers of doxorubicin-induced chronic cardiotoxicity in B6C3F<sub>1</sub> miceVarsha G Desai, Taewon Lee, Carrie L Moland, et al.
Transfusion|February 5, 2015
Evaluation of different testing methods for identification of RhIG in red blood cell antibody detectionKael V Mikesell, Melissa R George, William J Castellani, et al.
Journal of the National Medical Association|April 29, 1998
Diabetes mellitus and its complications in an African-American community: project DIRECTW H Herman, T J Thompson, W Visscher, et al.
Diabetes Care|July 29, 2003
The direct medical cost of type 2 diabetesMichael Brandle, Honghong Zhou, Barbara R K Smith, et al.
Clinical and Experimental Rheumatology|January 1, 1987
Clinical manifestations in HLA-B27-positive patientsR Joos, E M Veys, H Mielants, et al.
Annals of Internal Medicine|February 14, 2022
The National Clinical Care Commission Report: Improving Federal Programs That Impact Diabetes Prevention and Care, Paul R Conlin, Carol Greenlee, et al.
Pageof 90

Showing results (651-660 of 892) with videos related to

Sort By:
Pageof 90
Transfusion|October 11, 2011
RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME)Jenny M Despotovic, Michele P Lambert, Jay H Herman, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 16, 2012
Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and ComplicationsW H Herman, R Pop-Busui, B H Braffett, et al.
Calcified Tissue International|January 1, 1980
Effects of 1 alpha-hydroxy vitamin D3 on the rachitic chick intestine: a comparison to the effects of 1,25-dihydroxyvitamin D3D D Bikle, R N Empson, R L Morrissey, et al.
Diabetes Care|September 30, 2003
Improving diabetes processes of care in managed careLiza L Ilag, Catherine L Martin, Bahman P Tabaei, et al.
Toxicology and Applied Pharmacology|December 6, 2018
Candidate early predictive plasma protein markers of doxorubicin-induced chronic cardiotoxicity in B6C3F<sub>1</sub> miceVarsha G Desai, Taewon Lee, Carrie L Moland, et al.
Transfusion|February 5, 2015
Evaluation of different testing methods for identification of RhIG in red blood cell antibody detectionKael V Mikesell, Melissa R George, William J Castellani, et al.
Journal of the National Medical Association|April 29, 1998
Diabetes mellitus and its complications in an African-American community: project DIRECTW H Herman, T J Thompson, W Visscher, et al.
Diabetes Care|July 29, 2003
The direct medical cost of type 2 diabetesMichael Brandle, Honghong Zhou, Barbara R K Smith, et al.
Clinical and Experimental Rheumatology|January 1, 1987
Clinical manifestations in HLA-B27-positive patientsR Joos, E M Veys, H Mielants, et al.
Annals of Internal Medicine|February 14, 2022
The National Clinical Care Commission Report: Improving Federal Programs That Impact Diabetes Prevention and Care, Paul R Conlin, Carol Greenlee, et al.
Pageof 90